• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列帕金森病发病率下降(2002 - 2021年)。

Declining incidence of Parkinson's disease in Israel (2002-2021).

作者信息

Balash Yacov, Zohar Tamar, Gilad Ronit, Eilam Anda, Korczyn Amos D

机构信息

Department of Neurology, Kaplan Medical Center, 76100, Rehovot, Israel.

The Hebrew University of Jerusalem, 91120, Jerusalem, Israel.

出版信息

J Neural Transm (Vienna). 2025 Jul 22. doi: 10.1007/s00702-025-02984-2.

DOI:10.1007/s00702-025-02984-2
PMID:40694141
Abstract

The results of investigations of the trends of the incidence of Parkinson's disease (PD) over time in numerous developed countries showed that aging and increasing life expectancy are leading to an increase in both. We investigated the crude and age-adjusted incidence rates (AAIRs) of PD based upon registry data of Israel's largest health maintenance organization between 2002 and 2021 according to joinpoint regression. We applied an age-period analysis to further identify patterns of AAIR changes, and calculated longitudinal age curves of PD rates ("local drift") as well as annual change of the expected age-specific and expected age-adjusted AAIR ("net drift"). The overall AAIR of PD declined from 57 ± 1.0 to 20.3 ± 0.5 per 100,000 over 20 years, representing a 2.8-fold decrease. The PD incidence decreased more rapidly among females (average annual percent changes [AAPC] - 5.3%, 95% confidence interval [CI] - 6.0-4.6, p < 0.001) than among males (AAPC - 4.5, 95%CI - 5.3-3.7, p < 0.001). AAIRs peaked at 209.9 (CI: 193.0-228.5) per 100,000 at a median age of 77.5 vs. 374.9 (CI: 350.9-400.5) years in females and at a median age of 82.5 years in males. AAIRs gradually declined in males to 63.3 (CI: 52.2-84.1) per 100,000 and in females to 29.7 (CI: 21.4-41.1) per 100,000 for the 97.5-year-old group in both sexes. This first assessment of the trends of the incidence of PD in Israel documented its progressive decline from 2002 to 2021, especially among the very elderly. This decline may reflect refined diagnostic capabilities and enhanced health, quality of life and environmental conditions in Israel.

摘要

对众多发达国家帕金森病(PD)发病率随时间变化趋势的调查结果表明,老龄化和预期寿命的增加导致两者都在上升。我们根据2002年至2021年以色列最大的健康维护组织的登记数据,通过连接点回归研究了PD的粗发病率和年龄调整发病率(AAIRs)。我们应用年龄-时期分析来进一步确定AAIR变化的模式,并计算了PD发病率的纵向年龄曲线(“局部漂移”)以及预期年龄特异性和预期年龄调整AAIR的年度变化(“净漂移”)。在20年的时间里,PD的总体AAIR从每10万人57±1.0下降到20.3±0.5,下降了2.8倍。女性中PD发病率下降得比男性更快(平均年度百分比变化[AAPC]为-5.3%,95%置信区间[CI]为-6.0至-4.6,p<0.001)(男性AAPC为-4.5,95%CI为-5.3至-3.7,p<0.001)。女性AAIR在中位年龄77.5岁时达到峰值,为每10万人209.9(CI:193.0至228.5),男性在中位年龄82.5岁时达到峰值,为每10万人374.9(CI:350.9至400.5)。在97.5岁年龄组中,男性AAIR逐渐下降到每10万人63.3(CI:52.2至84.1),女性下降到每10万人29.7(CI:21.4至41.1)。对以色列PD发病率趋势的首次评估记录了其从2002年到2021年的逐渐下降,尤其是在老年人中下降更为明显。这种下降可能反映了以色列诊断能力的提高以及健康、生活质量和环境条件的改善。

相似文献

1
Declining incidence of Parkinson's disease in Israel (2002-2021).以色列帕金森病发病率下降(2002 - 2021年)。
J Neural Transm (Vienna). 2025 Jul 22. doi: 10.1007/s00702-025-02984-2.
2
Increasing Trends of Pediatric Thoracic and Lumbar Spine Fractures in the United States from 2004 to 2023: A 20-year National Injury Review Depicting Shifts in Mechanisms of Injury.2004年至2023年美国儿童胸腰椎骨折的增长趋势:一项为期20年的全国性损伤回顾,描绘损伤机制的变化
Clin Orthop Relat Res. 2025 Feb 25. doi: 10.1097/CORR.0000000000003421.
3
Are There Sex Differences in the Association of Alcohol Consumption With the Risk of Soft Tissue Sarcoma? A Nationwide Population-based Study in Korea.饮酒与软组织肉瘤风险之间的关联存在性别差异吗?韩国一项基于全国人口的研究。
Clin Orthop Relat Res. 2025 Jun 25. doi: 10.1097/CORR.0000000000003602.
4
Temporal trends in the incidence of adverse effects of medical treatment in BRICS countries from 1990 to 2021: an age-period cohort analysis.1990年至2021年金砖国家医疗不良事件发生率的时间趋势:年龄-时期队列分析
Front Public Health. 2025 Jun 24;13:1508272. doi: 10.3389/fpubh.2025.1508272. eCollection 2025.
5
Incidence and disability-adjusted life-years of infective endocarditis in China from 1990 to 2021: comparison with G20 based on the Global Burden of Disease Study 2021.1990年至2021年中国感染性心内膜炎的发病率和伤残调整生命年:基于《2021年全球疾病负担研究》与二十国集团的比较
BMJ Open. 2025 Jul 6;15(7):e094490. doi: 10.1136/bmjopen-2024-094490.
6
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
7
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.

本文引用的文献

1
Immunotherapy and its racial specificity for breast cancer treatment in Asia: a narrative review.免疫疗法及其在亚洲乳腺癌治疗中的种族特异性:一项叙述性综述。
Lancet Reg Health West Pac. 2024 Sep 19;57:101180. doi: 10.1016/j.lanwpc.2024.101180. eCollection 2025 Apr.
2
Global, regional, national epidemiology and trends of Parkinson's disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021.1990年至2021年帕金森病的全球、区域、国家流行病学及趋势:全球疾病负担研究2021的结果
Front Aging Neurosci. 2025 Jan 10;16:1498756. doi: 10.3389/fnagi.2024.1498756. eCollection 2024.
3
Does Bisphenol A (BPA) Exposure Cause Human Diseases?
双酚A(BPA)暴露会引发人类疾病吗?
Biomedicines. 2024 Nov 25;12(12):2678. doi: 10.3390/biomedicines12122678.
4
Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.帕金森病的环境风险因素:批判性综述及政策启示
Mov Disord. 2025 Feb;40(2):204-221. doi: 10.1002/mds.30067. Epub 2024 Nov 27.
5
Exploring the potential mechanism of atrazine-induced dopaminergic neurotoxicity based on integration strategy.基于整合策略探讨莠去津诱导的多巴胺能神经毒性的潜在机制。
Environ Health Prev Med. 2024;29:46. doi: 10.1265/ehpm.24-00079.
6
Rethinking Parkinson's Disease: A Syndromic Perspective.重新审视帕金森病:综合征视角
Mov Disord. 2024 Jun;39(6):1079-1080. doi: 10.1002/mds.29833.
7
Assessing the factors that influence the utilization and delivery of rehabilitation services among persons with Parkinson's disease: A scoping review.评估影响帕金森病患者康复服务利用和提供的因素:范围综述。
J Eval Clin Pract. 2024 Sep;30(6):873-886. doi: 10.1111/jep.13999. Epub 2024 May 16.
8
The Role of Diet in Parkinson's Disease.饮食在帕金森病中的作用。
J Parkinsons Dis. 2024;14(s1):S21-S34. doi: 10.3233/JPD-230264.
9
The epidemiology of Parkinson's disease.帕金森病的流行病学。
Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8.
10
Effects of defoliant exposure and medication use on the development of Parkinson's disease in veterans.落叶剂暴露和药物使用对退伍军人帕金森病发展的影响。
Age Ageing. 2023 Oct 2;52(10). doi: 10.1093/ageing/afad192.